Compare DexCom, Inc. (DXCM) vs United Airlines Holdings Inc (UAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs United Airlines Holdings Inc — how do they compare? DexCom, Inc. trades at $84.14 (market cap $31.86B), while United Airlines Holdings Inc trades at $107.46 (market cap $34.87B). The key difference: DexCom, Inc. and United Airlines Holdings Inc are close in size by market cap, and DexCom, Inc. is trading nearer its 52-week high, United Airlines Holdings Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and United Airlines Holdings Inc for 46 Days on average.
| DXCM | UAL | |
|---|---|---|
Market Cap | $31.86B | $34.87B |
Volume | 3,607,070 | 6,329,678 |
Sector | Health | Industrials |
52-Week High | $92.34 | $136.11 |
52-Week Low | $54.84 | $85.21 |
Typical Hold Time | 62 Days | 46 Days |
Enterprise Value | $31.32B | $51.90B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.11, down 0.23% on the day, with a bearish technical signal but strong fundamental performance. The company reported Q2 2026 EPS of $0.70, beating expectations, and has shown consistent revenue growth, with 2025 revenue reaching $4.66 billion and net income of $836.3 million. Analyst consensus is strongly bullish with an 80.77% buy rating and a $95.07 price target. Recent news highlights growth opportunities in Type 2 diabetes care and key executive promotions.
The outlook for DXCM is positive due to robust earnings beats, expanding market opportunities, and strong institutional support. However, risks include competitive pressures, reimbursement challenges, and a high valuation with a P/E of 33.38. The stock presents a growth opportunity but requires monitoring of execution against these risks.
United Airlines (UAL) trades at $107.46, down 2.46% with a bearish technical signal despite strong fundamentals. The stock shows attractive valuation metrics with P/E of 10.1 and P/S of 0.6, supported by consistent earnings beats and improving profitability. Recent news highlights aggressive customer acquisition strategies targeting Delta's premium travelers through status-match offers and Starlink-enabled WiFi advantages.
UAL presents a compelling value opportunity with analyst consensus price target of $158.10 (47% upside) and unanimous buy/hold ratings. However, near-term headwinds include rising fuel costs, labor expenses, and technical weakness. The company's strong cash flow generation and strategic positioning for premium customer capture support long-term growth prospects despite current market pessimism.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About United Airlines Holdings Inc
United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →
